Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific th1 and th17 cells in anterior chamber-associated immune deviation (ACAID)

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5811-5817

  Cui, Yan ^a,b   Shao, Hui ^a   Sun, Deming ^a,b   Kaplan, Henry J ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 17; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN[1-20]; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN[161-180]; UNCLASSIFIED DRUG; EYE PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; RETINOL BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION; ANTERIOR EYE CHAMBER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RETINA; SPLEEN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UVEITIS; VITREOUS BODY; ANIMAL; ANTIGEN PRESENTING CELL; C57BL MOUSE; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GERMFREE ANIMAL; IMMUNOLOGY; IRIDOCYCLITIS; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTERIOR CHAMBER; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RETINOL-BINDING PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; UVEITIS, ANTERIOR;

EID: 73349134680     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3389     Document Type: Article

References (19)

1. + T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol. 2004;172:1991-1995
2. Hara Y, Caspi RR, Wiggert B, et al. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis. Curr Eye Res. 1992;11:97-100.
3. Thurau SR, Chan CC, Nussenblatt RB, Caspi RR. Oral tolerance in a murine model of relapsing experimental autoimmune uveoreti-nitis (EAU): induction of protective tolerance in primed animals. Clin Exp Immunol. 1997;109:370-376.
4. Shao H, Liao T, Ke Y, et al. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res. 2006;82:323-331
5. + interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2007;48:4153-4161.
6. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med. 1981;153:1058-1067.
7. Waldrep JC, Kaplan HJ. Cyclophosphamide-sensitive contrasup-pression in TNP-anterior chamber associated immune deviation (TNP-ACAID). J Immunol. 1983;131:2746-2750.
8. Mizuno K, Clark AF, Streilein JW. Anterior chamber-associated immune deviation induced by soluble antigens. Invest Ophthalmol Vis Sci. 1989;30:1112-1119
9. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID), II: eye-derived cells participate in generating blood-borne signals that induce ACAID.JImmunol. 1991;146:3018-3024.
10. Geiger K, Sarvetnick N. Local production of IFN-7 abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J Immunol. 1994;153:5239-5246.
11. Kosiewicz MM, Streilein JW. Intraocular injection of class II-re-stricted peptide induces an unexpected population of CD8 regulatory cells. J Immunol. 1996;157:1905-1912.
12. Wang Y, Goldschneider I, Foss D, et al. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extra-thymic antigens in adult mice. J Immunol. 1997;158:2150-2155
13. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132.
14. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-1141.
15. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
16. Ashour HM, Niederkorn JY. 7S T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. JImmunol. 2006;177:8331-8337.
17. + CTL responses. Invest Ophthalmol Vis Sci. 2002;43:3473-3479.
18. Shao H, Van Kaer L, Sun SL, et al. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J Autoimmunity. 2003;21:37-45.
19. Grajewski RS, Hansen AM, Agarwal RK, et al. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-7 production and dampening of the adaptive Th1 and Th17 responses. J Immunol. 2008;181: 4791-4797.